These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells. Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121 [TBL] [Abstract][Full Text] [Related]
24. Chemical Modifications for a Next Generation of Nucleic Acid Aptamers. Chan KY; Kinghorn AB; Hollenstein M; Tanner JA Chembiochem; 2022 Aug; 23(15):e202200006. PubMed ID: 35416400 [TBL] [Abstract][Full Text] [Related]
25. Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review. Pang X; Cui C; Wan S; Jiang Y; Zhang L; Xia L; Li L; Li X; Tan W Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29425173 [TBL] [Abstract][Full Text] [Related]
26. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine. Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890 [TBL] [Abstract][Full Text] [Related]
27. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics. Zhong Y; Zhao J; Li J; Liao X; Chen F Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127 [TBL] [Abstract][Full Text] [Related]
28. An exploration of aptamer internalization mechanisms and their applications in drug delivery. Wan LY; Yuan WF; Ai WB; Ai YW; Wang JJ; Chu LY; Zhang YQ; Wu JF Expert Opin Drug Deliv; 2019 Mar; 16(3):207-218. PubMed ID: 30691313 [TBL] [Abstract][Full Text] [Related]
29. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids. Macedo B; Cordeiro Y Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534 [TBL] [Abstract][Full Text] [Related]
31. DNA and RNA aptamers: from tools for basic research towards therapeutic applications. Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882 [TBL] [Abstract][Full Text] [Related]
32. SELEX methods on the road to protein targeting with nucleic acid aptamers. Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856 [TBL] [Abstract][Full Text] [Related]
33. Current Advances in Aptamers for Cancer Diagnosis and Therapy. Hori SI; Herrera A; Rossi JJ; Zhou J Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29301363 [TBL] [Abstract][Full Text] [Related]
34. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy. Wei Z; Zhou Y; Wang R; Wang J; Chen Z Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559056 [TBL] [Abstract][Full Text] [Related]
35. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. Fu Z; Xiang J Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316469 [TBL] [Abstract][Full Text] [Related]
36. Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications-The Role of Molecular Dynamics Simulation. Jeevanandam J; Tan KX; Danquah MK; Guo H; Turgeson A Biotechnol J; 2020 Mar; 15(3):e1900368. PubMed ID: 31840436 [TBL] [Abstract][Full Text] [Related]
37. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy. Zhu H; Li J; Zhang XB; Ye M; Tan W ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749 [TBL] [Abstract][Full Text] [Related]
38. Developing Aptamers by Cell-Based SELEX. Catuogno S; Esposito CL; de Franciscis V Methods Mol Biol; 2016; 1380():33-46. PubMed ID: 26552814 [TBL] [Abstract][Full Text] [Related]
39. Cell-SELEX: in vitro selection of synthetic small specific ligands. Dickinson H; Lukasser M; Mayer G; Hüttenhofer A Methods Mol Biol; 2015; 1296():213-24. PubMed ID: 25791604 [TBL] [Abstract][Full Text] [Related]